”la Caixa” Foundation devotes more than 23 million euros to 33 new biomedicine and health research projects in Spain and Portugal

Volver

”la Caixa” Foundation devotes more than 23 million euros to 33 new biomedicine and health research projects in Spain and Portugal

Enlaces recomendados

CaixaResearch Call for Proposals in Health Research 2022

Imprimir noticia

The fifth 2022 CaixaResearch Call for Proposals in Health Research will provide funding for 33 new cutting-edge biomedical research projects in the two countries, with grants of up to one million euros per project.

The call is aimed at basic, clinical or translational research initiatives of excellence and great potential impact that address health challenges in the fields of cardiovascular, infectious and oncological diseases, and neuroscience, as well as projects to develop enabling technologies in these fields.

The initiatives selected include, among others, projects to regenerate heart tissue after a heart attack; to decipher the impact of ‘jumping genes’ on tumour proliferation; to study how the gut microbiota influences loss of control of intake in obesity; to create a new technology to purify the air of respiratory viruses; and to develop therapeutic nanotechnology that can halt the progression of Parkinson’s disease.

Ver menos

SubirNota de prensa y documentación (1)

Press release: ”la Caixa” Foundation devotes more than 23 million euros to 33 new biomedicine and health research projects in Spain and Portugal

SubirImágenes (33)

Alfonso Jaramillo, del Instituto de Biología Integrativa de Sistemas (I2SysBio-CSIC) (Spain).

Almudena R. Ramiro, del Centro Nacional de Investigaciones Cardiovasculares Carlos III – CNIC. (Spain).

Andrés Aguilera, del Centro Andaluz de Biología Molecular y Medicina Regenerativa (CABIMER), Universidad de Sevilla (Spain).

Ángel BarcoÁngel Barco, del Instituto de Neurociencias, UMH-CSIC – Consejo Superior de Investigaciones Científicas (Spain).

Christian BranderChristian Brander, investigador ICREA en IrsiCaixa, Institut de Recerca de la Sida (Spain).

Claudio Franco, del Católica Biomedical Research Centre and Instituto de Medicina Molecular João Lobo Antunes (Portugal).

Cláudio Manuel Soares, del Instituto de Tecnologia Química e Biológica António Xavier (ITQB NOVA), Universidade NOVA de Lisboa (Portugal).

Cristina Cunha, del Instituto de Investigação em Ciências da Vida e Saúde (ICVS), Escola de Medicina, Universidade de Minho (Portugal).

Elías CampoElías Campo, del Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) (Spain).

Helena Florindo, de la Faculdade de Farmácia da Universidade de Lisboa (Portugal).

Fran Supek, del Institut de Recerca Biomèdica de Barcelona (IRB Barcelona) (Spain).

Esteban Ballestar, del Institut de Recerca contra la Leucèmia Josep Carreras (Spain).

Ira Milosevic, del Instituto Multidisciplinar del Envejecimiento, Universidade de Coimbra (Portugal).

João Morais Cabral, del i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto (Portugal).

Joaquín Arribas, del Institut Hospital del Mar d’Investigacions Mèdiques, IMIM-Hospital del Mar (Spain).

Jordi Figuerola, de la Estación Biológica de Doñana – Consejo Superior de Investigaciones Científicas (EBD-CSIC) (Spain).

José Javier Fuster, del Centro Nacional de Investigaciones Cardiovasculares Carlos III – CNIC (Spain).

José Tubio, del Centro de Investigación en Medicina Molecular y Enfermedades Crónicas (CiMUS), Universidad de Santiago de Compostela (Spain).

Josep Dalmau, del Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), y Thais Armangué, de la Fundació Privada per a la Recerca i la Docència Sant Joan de Déu (Spain).

Leopoldo Petreanu, de la Fundación Champalimaud (Portugal).

Luis Graca, del Instituto de Medicina Molecular (Portugal).

Manuela Ferreira, del Centro de Neurociências e Biologia Celular da Universidade de Coimbra (Portugal).

Marta Martínez-Vicente, del Vall d’Hebron Institut de Recerca (VHIR) (Spain).

Miguel A. Bañares, del Consejo Superior de Investigaciones Científicas (CSIC) (Spain).

Miguel SeabraMiguel Seabra, de la NOVA Medical School, Universidade NOVA de Lisboa, NMS|NOVA (Portugal).

Nuria Martínez, del Centro de Biología Molecular Severo Ochoa, CBMSO-CSIC (Spain).

Óscar Fernández-Capetillo, del Centro Nacional de Investigaciones Oncológicas- CNIO (Spain).

Patricia Pérez-Galán, del Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) (Spain).

Paulo Aguiar, del i3S – Instituto de Investigação e Inovação em Saúde, Universidade do Porto (Portugal).

Rafael Maldonado, de NeuroPhar-MELIS, Universitat Pompeu Fabra (UPF) (Spain).

Rui Benedito, del Centro Nacional de Investigaciones Cardiovasculares Carlos III – CNIC (Spain).

Teresa Correia, del Centro de Ciências do Mar do Algarve (CCMAR) (Portugal).

Vera Sofia Correia Martins, del Instituto Gulbenkian de Ciência (Portugal).

La Caixa

Sala de prensa

Enlaces recomendados

Compartir